2019
DOI: 10.1136/bmj.l313
|View full text |Cite
|
Sign up to set email alerts
|

How NHS investment in proton beam therapy is coming to fruition

Abstract: As the first national centres start to provide this developing radiotherapy technology in the UK, Matthew Limb reports on the hopes and expectations of doctors, policy makers, and patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…The Rutherford cancer centre in Wales was the first in the UK to offer high energy proton beam therapy. The US saw a big expansion in private proton therapy centres marketed heavily at men with prostate cancer but a number have since closed as insurers pulled out, seeing no proven additional benefit in the therapy compared with alternatives 12…”
mentioning
confidence: 99%
“…The Rutherford cancer centre in Wales was the first in the UK to offer high energy proton beam therapy. The US saw a big expansion in private proton therapy centres marketed heavily at men with prostate cancer but a number have since closed as insurers pulled out, seeing no proven additional benefit in the therapy compared with alternatives 12…”
mentioning
confidence: 99%
“…Limb reports that the potential benefits from expanding the indications for proton therapy should be evaluated in randomised clinical trials 1. In proton therapy, in which advantages in radiation dose distribution are usually used to reduce the severity of long term morbidity, randomised clinical trials with an endpoint decades later may be problematic.…”
mentioning
confidence: 99%